ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value ($000): $131,116 (100.0% shares, 0.0% debt)

Holdings (21)

IOVA IOVANCE BIOTHERAPEUTICS INC 20.4%

Value ($000) $26,720 Shares 3,019,201 Est. Cost $7.92 Unrealized +21.8%

— ASSEMBLY BIOSCIENCES INC 12.4%

Value ($000) $16,252 Shares 718,500 Est. Cost $16.39 Unrealized —

— KADMON HLDGS INC 12.0%

Value ($000) $15,679 Shares 7,538,000 Est. Cost $3.69 Unrealized —

— CAS MED SYS INC 6.4%

Value ($000) $8,422 Shares 5,263,508 Est. Cost $1.45 Unrealized —

XBI SPDR SERIES TRUST 5.5%

Value ($000) $7,175 Shares 100,000 Est. Cost — Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 5.3%

Value ($000) $6,934 Shares 187,500 Est. Cost $38.77 Unrealized —

— AMARIN CORP PLC 4.5%

Value ($000) $5,954 Shares 437,500 Est. Cost $14.04 Unrealized —

— IMMUNOMEDICS INC 4.4%

Value ($000) $5,708 Shares 400,000 Est. Cost $12.30 Unrealized —

— IMMUNOMEDICS INC 4.4%

Value ($000) $5,708 Shares 400,000 Est. Cost $12.30 Unrealized —

VCYT VERACYTE INC 4.2%

Value ($000) $5,567 Shares 442,500 Est. Cost $7.25 Unrealized +63.2%

IRIX IRIDEX CORP 4.2%

Value ($000) $5,520 Shares 1,174,500 Est. Cost $11.40 Unrealized -56.4%

ARGX ARGENX SE 3.9%

Value ($000) $5,092 Shares 53,000 Est. Cost $48.57 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 2.6%

Value ($000) $3,417 Shares 173,000 Est. Cost $15.20 Unrealized +32.3%

XENE XENON PHARMACEUTICALS INC 2.6%

Value ($000) $3,392 Shares 537,500 Est. Cost $6.81 Unrealized +30.5%

— ACER THERAPEUTICS INC 2.2%

Value ($000) $2,877 Shares 143,000 Est. Cost $21.25 Unrealized —

— CHEMBIO DIAGNOSTICS INC 1.7%

Value ($000) $2,191 Shares 387,167 Est. Cost $7.05 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 1.5%

Value ($000) $1,990 Shares 53,800 Est. Cost $38.77 Unrealized —

VRAYQ VIEWRAY INC 1.4%

Value ($000) $1,891 Shares 311,500 Est. Cost $6.35 Unrealized +18.0%

— SUTRO BIOPHARMA INC 0.3%

Value ($000) $410 Shares 45,500 Est. Cost $9.01 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS 0.2%

Value ($000) $202 Shares 25,000 Est. Cost $7.78 Unrealized 0.0%

— OUTLOOK THERAPEUTICS INC 0.0%

Value ($000) $15 Shares 29,082 Est. Cost $0.52 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IOVA	IOVANCE BIOTHERAPEUTICS INC	3,019,201	$26,720	20.4%	$7.92	+21.8%	COM	462260100
—	ASSEMBLY BIOSCIENCES INC	718,500	$16,252	12.4%	$16.39	—	COM	045396108
—	KADMON HLDGS INC	7,538,000	$15,679	12.0%	$3.69	—	COM	48283N106
—	CAS MED SYS INC	5,263,508	$8,422	6.4%	$1.45	—	COM PAR	124769209
XBI	SPDR SERIES TRUST	100,000	$7,175	5.5%	—	—	Put	78464A870
—	BIOHAVEN PHARMACTL HLDG CO L	187,500	$6,934	5.3%	$38.77	—	COM	G11196105
—	AMARIN CORP PLC	437,500	$5,954	4.5%	$14.04	—	SPONS ADR NEW	023111206
—	IMMUNOMEDICS INC	400,000	$5,708	4.4%	$12.30	—	COM	452907108
—	IMMUNOMEDICS INC	400,000	$5,708	4.4%	$12.30	—	Put	452907108
VCYT	VERACYTE INC	442,500	$5,567	4.2%	$7.25	+63.2%	COM	92337F107
IRIX	IRIDEX CORP	1,174,500	$5,520	4.2%	$11.40	-56.4%	COM	462684101
ARGX	ARGENX SE	53,000	$5,092	3.9%	$48.57	—	SPONSORED ADR	04016X101
KALV	KALVISTA PHARMACEUTICALS INC	173,000	$3,417	2.6%	$15.20	+32.3%	COM	483497103
XENE	XENON PHARMACEUTICALS INC	537,500	$3,392	2.6%	$6.81	+30.5%	COM	98420N105
—	ACER THERAPEUTICS INC	143,000	$2,877	2.2%	$21.25	—	COM	00444P108
—	CHEMBIO DIAGNOSTICS INC	387,167	$2,191	1.7%	$7.05	—	COM NEW	163572209
—	BIOHAVEN PHARMACTL HLDG CO L	53,800	$1,990	1.5%	$38.77	—	Call	G11196105
VRAYQ	VIEWRAY INC	311,500	$1,891	1.4%	$6.35	+18.0%	COM	92672L107
—	SUTRO BIOPHARMA INC	45,500	$410	0.3%	$9.01	—	COM	869367102
BCRX	BIOCRYST PHARMACEUTICALS	25,000	$202	0.2%	$7.78	0.0%	COM	09058V103
—	OUTLOOK THERAPEUTICS INC	29,082	$15	0.0%	$0.52	—	COM	69012T107